Disclaimer: All content on this site — including company research, ratings, price targets, and market commentary — is generated automatically by artificial intelligence and may or may not have been reviewed, fact-checked, or verified by any human analyst, editor, or financial professional. No representation or warranty, express or implied, is made as to the accuracy, completeness, timeliness, or reliability of any information presented. StockWatch.report and its operators accept no responsibility or liability whatsoever for any loss or damage arising from reliance on this content. Nothing on this site constitutes investment, financial, legal, or tax advice, or a recommendation or solicitation to buy or sell any security. This content is provided for informational purposes only and must not be used as the basis for any investment decision. The operators of StockWatch.report and their affiliates may hold long or short positions in securities discussed on this site at any time. You are solely responsible for your own investment decisions and should consult a qualified, licensed financial professional before acting on any information presented here. Use of this site is governed by, and subject to, our Terms and Conditions.
WULF TeraWulf Inc.WULF: TeraWulf Files 8-K Disclosing Q2 FY2026 Financials Showing $79.8M Net Loss on $82M Revenue
06 Oct 2026, 4:03 AM ETCHRW C.H. Robinson Worldwide, Inc.CHRW: C.H. Robinson Enters Material Agreement and Discloses Q2 FY2026 Financial Results via 8-K Filing
06 Oct 2026, 4:03 AM ETPTC PTC Inc.PTC: PTC Inc. Posts Strong Q3 FY2026 Results, Shares Surge 35% on Earnings Beat
06 Oct 2026, 4:03 AM ETCOIN Coinbase Global, Inc.COIN: Coinbase Discloses Senior Executive Departure Under Item 5.02
06 Oct 2026, 4:03 AM ETRXO RXO, Inc.RXO: Company Enters Material Agreement, Discloses Q2 FY2026 Results Amid 24% Single-Day Stock Surge
06 Oct 2026, 4:03 AM ETPCVX Vaxcyte, Inc.PCVX: Vaxcyte Discloses Clinical or Corporate Development Update via 8-K Filed October 5
06 Oct 2026, 4:03 AM ETAXGN AxoGen, Inc.AXGN: AxoGen Reports Q2 FY2026 Results — Revenue Tops $105M as Operating Income Turns Marginally Positive
02 Oct 2026, 3:58 PM ETECHO EchoStar CorporationECHO: EchoStar Files 8-K Disclosing Material Agreement and Asset Transaction
02 Oct 2026, 3:20 PM ETCTVA Corteva, Inc.CTVA: Corteva Files 8-K with Q2 FY2026 Financial Results Showing $1.97B Net Income
02 Oct 2026, 2:24 PM ETACCV Accelevation Holdings Corp. Class A Ordinary SharesACCV: Accelevation Holdings Files Multi-Item 8-K Disclosing Material Corporate Actions Across Five Reporting Areas
02 Oct 2026, 2:16 PM ET